BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31134394)

  • 21. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of histopathological growth pattern in predicting 3-year progression free survival after operation in patients with liver metastasis of colorectal cancer].
    Zhang YL; He HJ; Cheng J; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):26-31. PubMed ID: 33396983
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation.
    Albrecht MH; Wichmann JL; Müller C; Schreckenbach T; Sakthibalan S; Hammerstingl R; Bechstein WO; Zangos S; Ackermann H; Vogl TJ
    Eur J Radiol; 2014 Oct; 83(10):1752-8. PubMed ID: 25082480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
    Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
    Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.
    Latacz E; Höppener D; Bohlok A; Leduc S; Tabariès S; Fernández Moro C; Lugassy C; Nyström H; Bozóky B; Floris G; Geyer N; Brodt P; Llado L; Van Mileghem L; De Schepper M; Majeed AW; Lazaris A; Dirix P; Zhang Q; Petrillo SK; Vankerckhove S; Joye I; Meyer Y; Gregorieff A; Roig NR; Vidal-Vanaclocha F; Denis L; Oliveira RC; Metrakos P; Grünhagen DJ; Nagtegaal ID; Mollevi DG; Jarnagin WR; D'Angelica MI; Reynolds AR; Doukas M; Desmedt C; Dirix L; Donckier V; Siegel PM; Barnhill R; Gerling M; Verhoef C; Vermeulen PB
    Br J Cancer; 2022 Oct; 127(6):988-1013. PubMed ID: 35650276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
    Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
    World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model.
    Mavros MN; Hyder O; Pulitano C; Aldrighetti L; Pawlik TM
    J Surg Oncol; 2013 Apr; 107(5):481-5. PubMed ID: 22952157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rate of false-positive diagnosis of colorectal liver metastases in patients undergoing resection with the development of a novel, externally validated risk score.
    O'Reilly DJ; Hodson J; Pike TW; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; A Lodge JP; Mirza DF; Roberts KJ
    Surgery; 2018 Aug; 164(2):238-243. PubMed ID: 29751969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
    Sasaki K; Morioka D; Conci S; Margonis GA; Sawada Y; Ruzzenente A; Kumamoto T; Iacono C; Andreatos N; Guglielmi A; Endo I; Pawlik TM
    Ann Surg; 2018 Jan; 267(1):132-141. PubMed ID: 27763897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphatic patterns of colorectal liver metastases.
    Hadj AK; Malcontenti-Wilson C; Nikfarjam M; Christophi C
    J Surg Res; 2012 Apr; 173(2):292-8. PubMed ID: 21035136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.
    Rompianesi G; Pegoraro F; Ceresa CD; Montalti R; Troisi RI
    World J Gastroenterol; 2022 Jan; 28(1):108-122. PubMed ID: 35125822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
    Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
    Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
    Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
    Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
    Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.